12:00 AM
Jan 21, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BNC210: Phase I started

Last month, Ironwood began a U.S. Phase I trial of single and multiple doses of IW-2143 in healthy volunteers. Bionomics...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >